Online inquiry

IVTScrip™ mRNA-Human ACTG2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK10660MR)

This product GTTS-WK10660MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ACTG2 protein. This product can be used in Mitotic fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001199893.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 72
UniProt ID P63267
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ACTG2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK10660MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK14720MR IVTScrip™ mRNA-Human AHCYL1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AHCYL1
GTTS-WK1793MR IVTScrip™ mRNA-Human GPR44, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA GPR44
GTTS-WK11935MR IVTScrip™ mRNA-Human ADGRD2, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ADGRD2
GTTS-WK17700MR IVTScrip™ mRNA-Human APBB2, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA APBB2
GTTS-WK3585MR IVTScrip™ mRNA-Human FSHR, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA FSHR
GTTS-WK23495MR IVTScrip™ mRNA-Human ARHGAP30, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP30
GTTS-WK9459MR IVTScrip™ mRNA-Human ACTG1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ACTG1
GTTS-WK21226MR IVTScrip™ mRNA-Human ANKRD44, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANKRD44
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →